Hadar Cohen
Tel Litwinsky, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Vibrio campbellii encodes a distinct set of type III secretion system effectors that mediate cytotoxicity in eukaryotic host models.
Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026
Genomic alterations in pediatric tumors: clinical relevance and translational insights.
Journal: Pediatric research
Published: September 12, 2025
Assessing toxicity and competitive fitness of Vibrio isolates from coastal waters in Israel.
Journal: mSphere
Published: April 02, 2025
The coral pathogen Vibrio coralliilyticus uses a T6SS to secrete a group of novel anti-eukaryotic effectors that contribute to virulence.
Journal: PLoS biology
Published: March 20, 2024
Development of Nontoxic Peptides for Lipopolysaccharide Neutralization and Sepsis Treatment.
Journal: ACS pharmacology & translational science
Published: January 22, 2024
A Vibrio T6SS-Mediated Lethality in an Aquatic Animal Model.
Journal: Microbiology spectrum
Published: June 13, 2023
Discovery of a Novel Missense Variant in NLRP3 Causing Atypical Cryopyrin-Associated Periodic Syndromes With Hearing Loss as the Primary Presentation, Responsive to Anti-Interleukin-1 Therapy.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 11, 2023
Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients.
Journal: Frontiers in immunology
Published: December 26, 2022
Post-phagocytosis activation of NLRP3 inflammasome by two novel T6SS effectors.
Journal: eLife
Published: August 17, 2022
Proteomic analysis of necroptotic extracellular vesicles.
Journal: Cell death & disease
Published: May 02, 2021
Vibrio pore-forming leukocidin activates pyroptotic cell death via the NLRP3 inflammasome.
Journal: Emerging microbes & infections
Published: February 05, 2020
Last Updated: 09/26/2026